We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

109 hedge funds and large institutions have $165M invested in Surgalign Holdings, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 32 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

2% more funds holding

Funds holding: 107109 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 32

18% less capital invested

Capital invested by funds: $200M → $165M (-$35.1M)

Holders
109
Holders Change
+2
Holders Change %
+1.87%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
32
Reduced
32
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PCMI
1
Paradigm Capital Management Inc
New York
$23.4M +$519K +3,987 +2%
BlackRock
2
BlackRock
New York
$18.5M +$218K +1,675 +1%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$17.6M +$406K +3,115 +2%
KAM
4
Krensavage Asset Management
New York
$16.4M -$81K -622 -0.4%
Vanguard Group
5
Vanguard Group
Pennsylvania
$10.9M +$318K +2,441 +3%
RSCM
6
Rock Springs Capital Management
Maryland
$7.21M
Renaissance Technologies
7
Renaissance Technologies
New York
$5.12M -$1.06M -8,166 -15%
Wellington Management Group
8
Wellington Management Group
Massachusetts
$4.53M +$1.31M +10,078 +33%
HC
9
Hillman Company
Pennsylvania
$4M
State Street
10
State Street
Massachusetts
$3.85M -$112K -860 -2%
RA
11
Royce & Associates
New York
$3.61M -$279K -2,141 -6%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$3.57M -$80.1K -615 -2%
FP
13
Foundry Partners
Minnesota
$3.34M -$52K -399 -1%
KIA
14
Kopp Investment Advisors
Minnesota
$3.21M -$128K -982 -3%
BCM
15
Bridgeway Capital Management
Texas
$2.68M +$177K +1,356 +6%
Russell Investments Group
16
Russell Investments Group
United Kingdom
$2.56M +$1.67M +12,844 +125%
Northern Trust
17
Northern Trust
Illinois
$2.54M +$54.1K +415 +2%
AL
18
AJO LP
Pennsylvania
$2.3M +$65K +499 +2%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$2.19M +$108K +828 +4%
RCM
20
Rutabaga Capital Management
Massachusetts
$2.18M -$3.55M -27,238 -58%
Boston Partners
21
Boston Partners
Massachusetts
$1.58M +$594K +4,562 +47%
Victory Capital Management
22
Victory Capital Management
Texas
$1.28M +$12.5K +96 +0.8%
WCM
23
Wedge Capital Management
North Carolina
$1.2M
Morgan Stanley
24
Morgan Stanley
New York
$1.02M +$249K +1,908 +26%
Marshall Wace
25
Marshall Wace
United Kingdom
$971K +$852K +6,543 +297%

SRGA Hedge Fund Activity: Q4 2018 in Review

109 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q4 2018, worth a combined $165M — down 18% from $200M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new SRGA positions and 12 closed out — a net gain of 2 holders — while 32 added to existing stakes and 32 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $1.67M. The largest seller was Rutabaga Capital Management, cutting an estimated $3.55M.

  • 109 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q4 2018, up from 107 in Q3 2018.
  • Funds reported $165M of Surgalign Holdings, Inc. Common Stock stock for Q4 2018, down 18% quarter-over-quarter.
  • 14 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q4 2018 and 12 closed out, a net change of +2 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q4 2018 was Russell Investments Group, an estimated $1.67M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q4 2018 was Rutabaga Capital Management, an estimated $3.55M sold.

Based on aggregated 13F filings for Q4 2018.